Annual Operating Expenses
$125.61 M
-$4.66 M-3.57%
December 31, 2023
Summary
- As of February 10, 2025, ACOR annual total operating expenses is $125.61 million, with the most recent change of -$4.66 million (-3.57%) on December 31, 2023.
- During the last 3 years, ACOR annual operating expenses has fallen by -$80.74 million (-39.13%).
Performance
ACOR Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Expenses
$29.97 M
-$937.00 K-3.03%
March 31, 2024
Summary
- As of February 10, 2025, ACOR quarterly total operating expenses is $29.97 million, with the most recent change of -$937.00 thousand (-3.03%) on March 31, 2024.
- Over the past year, ACOR quarterly operating expenses has dropped by -$1.62 million (-5.13%).
Performance
ACOR Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ACOR Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.6% | -5.1% |
| 3 y3 years | -39.1% | -35.4% |
| 5 y5 years | -55.2% | -58.0% |
ACOR Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -24.1% | at low | -23.7% | -24.6% |
| 5 y | 5-year | -54.9% | at low | -48.3% | -24.6% |
| alltime | all time | -71.4% | -78.4% | -73.5% | -70.7% |
Acorda Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $29.97 M(-3.0%) |
| Dec 2023 | $125.61 M(-3.6%) | $30.91 M(-3.6%) |
| Sep 2023 | - | $32.05 M(+3.2%) |
| Jun 2023 | - | $31.07 M(-1.7%) |
| Mar 2023 | - | $31.59 M(+39.8%) |
| Dec 2022 | $130.27 M(-21.3%) | $22.59 M(-29.6%) |
| Sep 2022 | - | $32.07 M(-18.4%) |
| Jun 2022 | - | $39.28 M(+8.1%) |
| Mar 2022 | - | $36.32 M(-3.1%) |
| Dec 2021 | $165.58 M(-19.8%) | $37.50 M(-4.5%) |
| Sep 2021 | - | $39.24 M(-7.5%) |
| Jun 2021 | - | $42.43 M(-8.6%) |
| Mar 2021 | - | $46.41 M(+3.4%) |
| Dec 2020 | $206.35 M(-25.9%) | $44.89 M(-15.9%) |
| Sep 2020 | - | $53.35 M(+3.4%) |
| Jun 2020 | - | $51.60 M(-8.7%) |
| Mar 2020 | - | $56.50 M(-2.5%) |
| Dec 2019 | $278.56 M(-0.6%) | $57.94 M(-20.0%) |
| Sep 2019 | - | $72.47 M(-5.7%) |
| Jun 2019 | - | $76.84 M(+7.8%) |
| Mar 2019 | - | $71.32 M(+11.6%) |
| Dec 2018 | $280.31 M(-24.5%) | $63.88 M(-4.2%) |
| Sep 2018 | - | $66.67 M(-6.0%) |
| Jun 2018 | - | $70.89 M(-10.1%) |
| Mar 2018 | - | $78.88 M(-19.9%) |
| Dec 2017 | $371.48 M(-15.4%) | $98.42 M(+33.0%) |
| Sep 2017 | - | $74.03 M(-26.4%) |
| Jun 2017 | - | $100.52 M(+2.0%) |
| Mar 2017 | - | $98.52 M(-12.7%) |
| Dec 2016 | $438.87 M(+23.7%) | $112.85 M(+3.0%) |
| Sep 2016 | - | $109.58 M(-2.9%) |
| Jun 2016 | - | $112.90 M(+9.0%) |
| Mar 2016 | - | $103.55 M(+6.8%) |
| Dec 2015 | $354.84 M(+28.9%) | $96.97 M(+2.7%) |
| Sep 2015 | - | $94.41 M(+12.3%) |
| Jun 2015 | - | $84.05 M(+5.8%) |
| Mar 2015 | - | $79.41 M(-3.6%) |
| Dec 2014 | $275.28 M | $82.38 M(+27.9%) |
| Sep 2014 | - | $64.40 M(-4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $67.09 M(+9.2%) |
| Mar 2014 | - | $61.41 M(+0.2%) |
| Dec 2013 | $239.42 M(+7.6%) | $61.31 M(+9.1%) |
| Sep 2013 | - | $56.17 M(-8.2%) |
| Jun 2013 | - | $61.22 M(+0.8%) |
| Mar 2013 | - | $60.72 M(-4.8%) |
| Dec 2012 | $222.57 M(+16.8%) | $63.78 M(+22.3%) |
| Sep 2012 | - | $52.15 M(-8.3%) |
| Jun 2012 | - | $56.86 M(+14.3%) |
| Mar 2012 | - | $49.77 M(+8.1%) |
| Dec 2011 | $190.62 M(+16.8%) | $46.02 M(+5.1%) |
| Sep 2011 | - | $43.81 M(-16.0%) |
| Jun 2011 | - | $52.15 M(+7.2%) |
| Mar 2011 | - | $48.64 M(-1.9%) |
| Dec 2010 | $163.26 M(+30.7%) | $49.58 M(+28.7%) |
| Sep 2010 | - | $38.53 M(-5.4%) |
| Jun 2010 | - | $40.71 M(+17.1%) |
| Mar 2010 | - | $34.78 M(+3.7%) |
| Dec 2009 | $124.87 M(+13.6%) | $33.53 M(+6.1%) |
| Sep 2009 | - | $31.61 M(-0.6%) |
| Jun 2009 | - | $31.79 M(+13.8%) |
| Mar 2009 | - | $27.94 M(-8.1%) |
| Dec 2008 | $109.91 M(+55.7%) | $30.41 M(+4.8%) |
| Sep 2008 | - | $29.02 M(+13.2%) |
| Jun 2008 | - | $25.63 M(+3.1%) |
| Mar 2008 | - | $24.85 M(+7.3%) |
| Dec 2007 | $70.58 M(+61.5%) | $23.17 M(+34.4%) |
| Sep 2007 | - | $17.24 M(+10.5%) |
| Jun 2007 | - | $15.60 M(+7.1%) |
| Mar 2007 | - | $14.57 M(+27.9%) |
| Dec 2006 | $43.70 M(+26.9%) | $11.39 M(+0.5%) |
| Sep 2006 | - | $11.33 M(+4.3%) |
| Jun 2006 | - | $10.86 M(+7.4%) |
| Mar 2006 | - | $10.12 M(+15.3%) |
| Dec 2005 | $34.42 M(-13.8%) | $8.77 M(-4.7%) |
| Sep 2005 | - | $9.20 M(-61.2%) |
| Dec 2004 | $39.94 M(-36.9%) | - |
| Dec 2003 | $63.34 M(+133.4%) | - |
| Sep 2003 | - | $23.71 M |
| Jun 2003 | $27.14 M | - |
FAQ
- What is Acorda Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Acorda Therapeutics?
- What is Acorda Therapeutics annual operating expenses year-on-year change?
- What is Acorda Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Acorda Therapeutics?
- What is Acorda Therapeutics quarterly operating expenses year-on-year change?
What is Acorda Therapeutics annual total operating expenses?
The current annual operating expenses of ACOR is $125.61 M
What is the all time high annual operating expenses for Acorda Therapeutics?
Acorda Therapeutics all-time high annual total operating expenses is $438.87 M
What is Acorda Therapeutics annual operating expenses year-on-year change?
Over the past year, ACOR annual total operating expenses has changed by -$4.66 M (-3.57%)
What is Acorda Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of ACOR is $29.97 M
What is the all time high quarterly operating expenses for Acorda Therapeutics?
Acorda Therapeutics all-time high quarterly total operating expenses is $112.90 M
What is Acorda Therapeutics quarterly operating expenses year-on-year change?
Over the past year, ACOR quarterly total operating expenses has changed by -$1.62 M (-5.13%)